RAMM Pharma Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAMMF research report →
Price Chart
About the company
RAMM Pharma Corp. is involved in the complete cycle of researching, developing, manufacturing, and commercializing a diverse array of cannabinoid-derived products. The company's extensive portfolio, available both in Canada and across international markets, encompasses specialized cannabinoid pharmaceutical formulations, conventional pharmaceuticals, cosmetics, and nutritional supplements.
- CEO
- Jackie Peter Burnett
- IPO
- 2020
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on RAMMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $15.16M
- P/E
- -0.14
- PEG
- -0.00
- P/S
- 0.63
- P/B
- 0.27
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
- Gross Margin
- 2.84%
- Op Margin
- -227.30%
- Net Margin
- -460.63%
- ROE
- -127.50%
- ROIC
- -97.96%
- 52W High
- $0.23
- 52W Low
- $0.06
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- -0.60
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for RAMMF yet.
- Free Float
- 32.9%
- Shares Outstanding
- 275.57M
- Float Shares
- 90.71M
Our RAMMF coverage
Recent articles, reports, and earnings notes.
No research on RAMMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RAMMF report →RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.
globenewswire.com · Nov 13
RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders
globenewswire.com · Nov 7
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
globenewswire.com · May 30
RAMM Pharma Corp. Provides Update on Canapar
globenewswire.com · Jan 21
RAMM Pharma Corp. Provides Update on Litigation
globenewswire.com · Dec 11
RAMM Pharma Corp. Provides Update on Litigation
globenewswire.com · May 21
RAMM Pharma Corp. Announces Corporate Update
globenewswire.com · Mar 28
RAMM Pharma Corp. Announces Corporate Update
globenewswire.com · Mar 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.